Evidence map›Paper›PMID 42207615›Full record

ArticleKidney3602026

Iron-ing Out the Role of Transferrin Receptor in Kidney Development.

Leslie S Gewin, Michael F Romero

Abstract read
In one paragraph

Article in Kidney360, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Leslie S GewinDivision of Nephrology, Department of Medicine, Washington University in St. Louis, St. Louis, Missouri.ORCID 0000-0002-6146-1092
Michael F RomeroPhysiology and Biomedical Engineering, Mayo Clinic College of Medicine and Science, Rochester, Minnesota.ORCID 0000-0002-1555-7835

Funding

TGF-beta Pathways that Protect Epithelia in Chronic Renal InjuryR01DK108968 · NIDDK · WASHINGTON UNIVERSITY · PI GEWIN, LESLIE S · 2016 to 2025
$3.7M
Role of Extracellular Vesicle: Autophagy Pathway Crosstalk in Type 2 Diabetes PathogenesisR01DK141438 · NIDDK · MAYO CLINIC ROCHESTER · PI JAVEED, NAUREEN · 2025 to 2025
$2.3M
Mayo Clinic Summer Undergraduate Research in Nephrology & UrologyR25DK101405 · NIDDK · MAYO CLINIC ROCHESTER · PI MICHAEL F. ROMERO · 2014 to 2026
$1.6M
Next Generation KUH Researchers (GENERATOR) Professional Development CoreU2CDK143937 · NIDDK · MAYO CLINIC ROCHESTER · PI MICHAEL F. ROMERO · 2025 to 2026
$1.1M
Resource Development CoreU54DK144863 · NIDDK · MAYO CLINIC ROCHESTER · PI Peter C. Harris · 2025 to 2026
$822k
NIDDK NIH HHS R01DK108968NIDDK NIH HHS R01DK141438NIDDK NIH HHS R25DK101405NIDDK NIH HHS U2CDK143937NIDDK NIH HHS U54DK144863U.S. Department of Veterans Affairs BX03425
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cystic kidneykidney developmentmineral metabolismnephron developmentpolycystic kidney diseasetransgenic mouse

Identifiers

PMID42207615
PMCPMC13229427

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.